当前位置: 首页 > 期刊 > 《中国民族民间医药·下半月》 > 2022年第2期
编号:257256
人参皂苷CK对肝脏的药理作用研究概况
http://www.100md.com 2022年5月30日 中国民族民间医药·下半月 2022年第2期
     浦滇 李俊 黄娜娜 刘雨珊 李芮 包崇卯 艾黎 饶高雄

    【摘要】人参皂苷CK为原人参二醇类人参皂苷,是口服原人参二醇后经肠道菌群的作用所产生的代谢产物,具有诸多药理活性。近年研究发现,人参皂苷CK具有抗肝癌、保护肝脏和抑制脂肪肝的药理作用。文章就人参皂苷CK对肝脏相关作用的国内外文献进行综述,以期为人参皂苷CK在肝脏相关疾病的临床应用研究提供依据。

    【关键词】人参皂苷CK;抗肝癌;保护肝脏;脂肪肝 ;肝毒性

    【中图分类号】R285.6【文献标志码】 A【文章编号】1007-8517(2022)04-0062-04

    Research Progress on Related Effects of Ginsenoside CK on Liver

    PU Dian1,2LI Jun1,2HUANG Nana1,2LIU Yushan1,2LI Rui3BAO Chongmao3AI Li3RAO Gaoxiong1,2

    1.Yunnan University of Chinese Medicine, Kunming 650500, China;

    2.Yunnan Provincial National Health Preservation Theory and Health Product Engineering Laboratory ,Kunming 650500, China;

    3.Yunnan Yunuo Biological Engineering limited liability company , Kunming 650217, China

    Abstract:Ginsenoside CK is protopanaxadiol ginsenoside, which is a metabolite produced by intestinal flora after oral administration of protopanaxadiol, and has many pharmacological activities. In recent years, studies have found that ginsenoside CK has a pharmacological effect of anti-liver cancer, protecting the liver and inhibiting fatty liver. In this paper ......

您现在查看是摘要页,全文长 14286 字符